1998
The company was formally established with a capital of 10,000,000 yuan, and its main business is the agency sales of electronic components.
2013
Biomedical was established.
2017
Signing a contract with CellSeed to obtain cell sheet technology / National Development Fund invested 100 million.
2018
Construction of the GTP laboratory complete.
2020
Signing a contract with Hitachi for joint investment in a CDMO automation cell factory / Approved for special regulation of fibroblast stem cell therapy / Performing the first autologous knee cartilage cell sheet transplan.
2021
Establishing LOCUS CELL with National Development Fund, Hitachi Asia Pacific and other companies as co-investors.
2022
Establishing LOCUS CELL with National Development Fund, Hitachi Asia Pacific and other companies as co-investors.